retatrutide glp-1 receptor agonist triple gip glucagon phase 2 nejm 2023 Medscape retatrutide mechanism trials Retatrutide, a

Farahzadi R, Sanaat Z, Movassaghpour-Akbari AA, Fathi E, Montazersaheb S

10.2147/JPR.S189443 J

While the current evidence base is promising, it is important to approach DSIP with realistic expectations

A head-to-head comparison trial (SURMOUNT-5) demonstrated that tirzepatide was superior to semaglutide for both weight reduction and waist circumference reduction at 72 weeks

N Engl J Med 384(11):9891002 Wilding JPHBR, Calanna S, Van Gaal LF, McGowan BM, Rosenstock J, Tran MTD, Wharton S, Yokote K, Zeuthen N, Kushner RF (2021) Impact of semaglutide on body composition in adults with overweight or obesity: exploratory analysis of the STEP 1 study

In addition, it has a wide variety of advantages for disorders associated with cognitive deficiencies of the brain, which reveals improvements in attention, memory, sociability and focus while reducing ASD symptom severity, and it does not have any negative effects on the body